What Is Primary Insomnia?
Primary insomnia (or chronic insomnia disorder) is a condition characterized by persistent difficulty initiating sleep, maintaining sleep, or obtaining sleep of adequate quality, despite appropriate opportunity and environment for sleeping. Symptoms occur at least three nights per week, for at least three months.
Insomnia is called "primary" when not secondary to another medical or psychiatric condition. However, current nomenclature (ICSD-3) prefers the term chronic insomnia disorder, recognizing that insomnia frequently coexists with other conditions and can be treated independently.
Chronic insomnia is not just an inconvenience — it is associated with serious health consequences, including increased risk of depression, anxiety, hypertension, cardiovascular disease, diabetes, and cognitive decline. Treating it adequately is a public-health concern.
Chronic Hyperarousal
Insomnia is not simply "being unable to sleep" — it is a state of nervous system hyperarousal that persists across the 24 hours, not just at night.
Neurobiologic Condition
Neuroimaging studies show changes in brain areas that regulate sleep-wakefulness. It is not "laziness" or "lack of discipline."
Effective Treatment without Medication
CBT for insomnia (CBT-I) is first-line treatment — more effective long-term than hypnotic medications.
Pathophysiology
The most accepted model for chronic insomnia is the hyperarousal model. Patients with insomnia show excessive activation of the brain's stress and alerting systems, which persists during the day and night, interfering with the capacity to transition into sleep.
Physiologic Hyperarousal
Patients with chronic insomnia show elevated levels of cortisol (especially at night), increased basal metabolic rate, elevated nocturnal body temperature, and higher heart rate during sleep. This shows that insomnia is not a state of "low activity," but rather of inappropriate hyperarousal.
Cortical Hyperarousal
EEG studies show increased beta and gamma wave activity (indicative of cortical alertness) during NREM sleep in insomniacs, when slow-wave dominance should normally prevail. PET-scan studies show that wake-promoting brain regions (such as the reticular activating system) remain excessively active during sleep.
The 3-P Model (Spielman)
The 3-P model explains the development of chronic insomnia: Predisposing factors (genetics, anxious temperament), Precipitating factors (acute stress, life change, illness), and Perpetuating factors (inadequate compensatory habits, worry about sleep, excessive time in bed). CBT-I acts mainly on perpetuating factors.
Symptoms
Insomnia presents with both nocturnal and daytime symptoms. Daytime symptoms are often as disabling as the difficulty sleeping — and are usually what leads patients to seek help.
Symptoms of Chronic Insomnia Disorder
- 01
Difficulty initiating sleep
Sleep latency above 30 minutes. The patient lies "tossing and turning," with a racing mind.
- 02
Frequent nighttime awakenings
Waking multiple times overnight with difficulty falling back asleep. Total nighttime wakefulness exceeds 30 minutes.
- 03
Early-morning awakening
Waking significantly earlier than desired, unable to return to sleep. Common in insomnia associated with depression.
- 04
Non-restorative sleep
Even when sleep duration seems adequate, the patient wakes unrested. Reflects altered sleep quality and architecture.
- 05
Daytime fatigue
Persistent tiredness throughout the day. Different from excessive sleepiness — the insomniac is tired but "too wired" to nap.
- 06
Difficulty concentrating
Deficits in sustained attention and working memory. Impacts productivity, error risk, and accidents.
- 07
Irritability and mood changes
Lower frustration tolerance and increased emotional reactivity. Significant impact on relationships.
- 08
Excessive worry about sleep
Anticipatory anxiety at bedtime, constant clock-watching, fear of not sleeping — which paradoxically worsens insomnia.
Diagnosis
Diagnosis of chronic insomnia is primarily clinical, based on patient history. Polysomnography is not necessary in most cases — it is reserved for when another sleep disorder is suspected, such as obstructive sleep apnea or periodic limb movements.
The sleep diary (filled out by the patient for 2 weeks) is the most valuable diagnostic tool. It records bedtimes, sleep latency, awakenings, wake times, and subjective sleep quality assessment. Wrist actigraphy may complement the diary with objective data.
🏥ICSD-3 Criteria for Chronic Insomnia Disorder
Fonte: International Classification of Sleep Disorders — 3rd Edition
Mandatory Criteria (all must be present)
All criteria must be met for diagnosis- 1.Complaint of difficulty initiating/maintaining sleep, or early-morning awakening
- 2.Adequate opportunity and circumstances for sleep
- 3.Daytime consequences attributable to insomnia (fatigue, cognitive deficit, mood changes)
- 4.Minimum frequency of 3 nights per week
- 5.Minimum duration of 3 months
DIFFERENTIAL DIAGNOSIS: INSOMNIA VS. OTHER SLEEP DISORDERS
| CONDITION | DISTINGUISHING FEATURE | INDICATED TEST |
|---|---|---|
| Obstructive sleep apnea | Snoring, breathing pauses, excessive daytime sleepiness | Polysomnography |
| Restless legs syndrome | Urge to move legs at bedtime, worsens with rest | Clinical + serum ferritin |
| Circadian rhythm disorder | Normal sleep at "natural" time — problem is timing | Sleep diary + actigraphy |
| Narcolepsy | Irresistible daytime sleepiness, cataplexy | Polysomnography + MSLT |
| Medication/substance-induced insomnia | Temporal correlation with caffeine, stimulants, alcohol use | Detailed clinical history |
| Depression/anxiety | Insomnia as symptom of primary disorder | Psychiatric evaluation — treat both |
DIAGNÓSTICO DIFERENCIAL
Differential Diagnosis
Obstructive Sleep Apnea
- Loud snoring
- Breathing pauses witnessed by partner
- Excessive daytime sleepiness
Testes Diagnósticos
- Polysomnography
- Nocturnal oximetry
Restless Legs Syndrome
Read more →- Need to move legs at bedtime
- Unpleasant sensation that worsens at rest
- Relieved by movement
Testes Diagnósticos
- IRLSSG criteria
Depression
Read more →- Terminal insomnia (early waking)
- Depressed mood
- Anhedonia
Testes Diagnósticos
- PHQ-9 scale
Generalized Anxiety
Read more →- Difficulty initiating sleep due to worries
- Nighttime rumination
- Muscle tension
Testes Diagnósticos
- GAD-7 scale
Insomnia from Inadequate Sleep Hygiene
- Irregular schedules
- Screen use until bedtime
- Late caffeine
Testes Diagnósticos
- Sleep diary
- Actigraphy
Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is the main diagnosis to rule out when evaluating insomnia, especially in patients with snoring, obesity, a large neck, or partner-reported breathing pauses. In OSA, the patient often has no difficulty falling asleep — the problem is sleep quality: multiple microarousals caused by upper-airway obstructions result in fragmented, non-restorative sleep and excessive daytime sleepiness.
The clinical distinction matters because treatment differs completely: OSA requires CPAP or mandibular advancement devices, not CBT-I. Polysomnography (PSG) is the gold-standard exam. In selected cases, nocturnal oximetry can serve as initial screening. Untreated OSA significantly increases cardiovascular risk.
Restless Legs Syndrome
Restless legs syndrome (RLS) is an important and underdiagnosed cause of difficulty falling asleep. The patient describes an unpleasant sensation in the legs (tingling, burning, internal itching, "crawling") that arises or worsens at rest — especially when lying down — and improves with movement. This sensation prevents the relaxation needed to fall asleep.
Diagnosis is clinical, based on IRLSSG criteria. Low ferritin is a treatable cause of RLS (iron replacement normalizes symptoms in many cases). Secondary causes include pregnancy, kidney failure, and neuropathy. Acupuncture has emerging evidence for relieving RLS symptoms and may be a complementary option, especially for patients who do not tolerate dopaminergic agents.
Insomnia Secondary to Psychiatric Disorders
Depression and anxiety are the most common psychiatric causes of insomnia. In depression, the most characteristic pattern is terminal insomnia — early-morning waking at 3-4 a.m. without being able to return to sleep — associated with depressed mood, anhedonia, and lack of energy. In generalized anxiety, the predominant pattern is sleep-onset insomnia — difficulty falling asleep due to nighttime ruminations and worries.
The distinction matters because treating the primary cause resolves secondary insomnia. When comorbidity exists (primary insomnia + depression), both should be treated simultaneously — CBT-I can be adapted to the context. Validated scales (PHQ-9 for depression, GAD-7 for anxiety) aid rapid screening.
Treatment
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment recommended by all international guidelines. It is more effective in the long term than any medication and has no side effects or risk of dependence.
CBT-I: Components
COMPONENTS OF CBT FOR INSOMNIA
| TECHNIQUE | DESCRIPTION | MECHANISM |
|---|---|---|
| Sleep restriction | Limit time in bed to actual sleep time (e.g., if sleeping 5 h, stay 5h30 in bed) | Increases homeostatic sleep pressure and consolidates sleep |
| Stimulus control | Use the bed only for sleep and sex; leave the bed if not asleep within 20 min | Reconditions the bed-sleep association (eliminates bed-wakefulness association) |
| Cognitive restructuring | Identify and modify dysfunctional beliefs about sleep | Reduces anticipatory anxiety and catastrophizing |
| Sleep hygiene | Adequate environment, consistent routine, avoid stimulants | Removes behavioral perpetuating factors |
| Relaxation techniques | Progressive muscle relaxation, diaphragmatic breathing | Reduces physiologic hyperarousal at bedtime |
Pharmacotherapy
Insomnia medications should be considered when CBT-I is unavailable, insufficient, or as a bridge while CBT-I takes effect. Use should be for the shortest time possible and always combined with behavioral measures.
MEDICATIONS FOR INSOMNIA
| MEDICATION | CLASS | MAIN INDICATION | CONSIDERATIONS |
|---|---|---|---|
| Zolpidem (5 mg initial dose in women, 5-10 mg in men, per FDA 2013 alert on next-morning impairment) | Non-benzodiazepine hypnotic | Difficulty initiating sleep | Short-term use (≤4 weeks); risk of dependence, tolerance, and amnestic phenomena |
| Suvorexant (10-20 mg) | Orexin antagonist | Difficulty initiating and maintaining sleep | Innovative mechanism; lower dependence risk |
| Trazodone (25-100 mg) | Sedating antidepressant | Insomnia with depressive/anxious component | Widely used off-label; favorable safety profile |
| Melatonin 0.5-5 mg | Sleep hormone | Circadian rhythm disorders (jet lag, shift work, phase delay/advance) | AASM 2017 does not recommend melatonin for primary insomnia in adults (insufficient evidence of benefit). May be considered in adults ≥55 years per European approval (Circadin prolonged release) |
| Doxepin (3-6 mg) | Tricyclic antidepressant (low dose) | Sleep maintenance | Approved for insomnia at ultra-low dose; well tolerated |
Week 1
Evaluation with sleep diary. Psychoeducation about normal sleep. Begin sleep hygiene and stimulus control.
Weeks 2-3
Implement sleep restriction. Relaxation techniques. Sleep may initially worsen (expected and temporary).
Weeks 4-6
Sleep consolidation. Cognitive restructuring of beliefs about sleep. Progressive improvement in sleep efficiency.
Weeks 6-8
Gradually expand time in bed as sleep improves. Most patients show significant improvement.
Maintenance
Habit consolidation. Relapse prevention. Strategies for handling occasional bad nights without regression.
Acupuncture as Treatment
Acupuncture has been studied as a complementary treatment for insomnia. Meta-analyses suggest it may improve subjective sleep quality and reduce sleep latency, especially when combined with other treatments.
Proposed mechanisms include possible autonomic nervous system modulation (relative reduction in sympathetic activity) and suggested effects on sleep-related neurotransmitters (GABA, serotonin, melatonin) and nocturnal cortisol — largely extrapolated from animal models and small studies. Biological plausibility justifies investigation, but does not replace adequate controlled clinical trials.
Acupuncture may be particularly useful as an adjunct for patients who want to reduce hypnotic use, or as a complement to CBT-I in cases of partial response. It does not replace CBT-I as first-line treatment.
Prognosis
With CBT-I, 70-80% of patients show significant improvement and results are durable — follow-up studies show maintenance of benefits for years. CBT-I is more effective in the long term than any medication for insomnia.
Without treatment, chronic insomnia tends to persist and worsen over time. It significantly increases the risk of developing depression (2x greater risk), anxiety, hypertension, and cardiovascular disease. Untreated chronic insomnia is also associated with increased mortality.
Good prognostic factors include: adherence to CBT-I techniques, absence of severe psychiatric comorbidity, willingness to tolerate the initial discomfort of sleep restriction, and long-term maintenance of regular habits.
Myths and Facts
Myth vs. Fact
Everyone needs exactly 8 hours of sleep per night.
Sleep need varies individually between 6 and 9 hours. What matters is quality and how the person feels during the day. Fixating on '8 hours' creates unnecessary anxiety and may worsen insomnia.
Myth vs. Fact
A glass of wine before bed helps you sleep better.
Alcohol can speed up sleep onset, but it severely fragments sleep in the second half of the night, reduces REM sleep, and worsens overall quality. It is one of the most common causes of sleep-maintenance insomnia.
Myth vs. Fact
If I cannot sleep, the best thing is to stay in bed trying until I fall asleep.
Staying in bed awake for more than 20 minutes strengthens the mental bed-wakefulness association. The recommendation is to get up, go to another room with low light, and return when sleepy. This reconditions the brain to associate the bed with sleep.
When to Seek Help
Insomnia does not need to be something you simply "live with." Highly effective treatments exist that can restore healthy sleep without medication dependence.
Frequently Asked Questions about Primary Insomnia
Primary insomnia (or Chronic Insomnia Disorder) is characterized by persistent difficulty initiating or maintaining sleep, or non-restorative sleep, for at least 3 nights per week over 3 months or more, causing significant daytime impairment — without another medical, psychiatric, or substance-related cause as the main cause. "Primary" means insomnia is the disorder itself, not a symptom of another condition. It is maintained by mechanisms of nervous system hyperexcitability and dysfunctional cognitions about sleep.
Nighttime symptoms include: difficulty initiating sleep (latency >30 minutes), frequent nighttime awakenings, early-morning awakening without being able to return to sleep, and a sense of non-restorative sleep. Daytime symptoms — frequently underestimated — include: fatigue or malaise, difficulty with concentration and memory, irritability or emotional instability, daytime sleepiness (paradoxically, not always present), excessive worry about sleep, and reduced performance at work or school.
Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured approach that addresses the mechanisms perpetuating insomnia: inadequate behaviors (sleep hygiene), dysfunctional cognitions ("I will never sleep," "I need exactly 8 hours"), and physiologic hyperexcitability. It includes stimulus control, sleep restriction, sleep hygiene, relaxation, and cognitive restructuring. It is first-line treatment because its effects are more durable than medications and it does not generate dependence — meta-analyses show superior long-term efficacy.
Generally not. Benzodiazepines and z-drugs (zolpidem, zopiclone) relieve insomnia short-term but carry risks with prolonged use: tolerance (needing higher doses), dependence, rebound insomnia on withdrawal, cognitive impairment (especially in older adults — risk of falls and dementia), and suppression of deep sleep. Guidelines recommend a maximum of 2-4 weeks of use. Prolonged-release melatonin (Circadin) is approved in Europe for adults ≥55 years with primary insomnia; the AASM considers the evidence weak for primary insomnia in general.
Systematic reviews suggest acupuncture may improve subjective sleep quality and reduce sleep latency compared with placebo, with limited-to-moderate evidence quality and important methodologic heterogeneity (difficult blinding, subjective outcomes). Proposed mechanisms include autonomic modulation and possible influence on sleep neurotransmitters — still under investigation. Acupuncture may be considered adjunctive to CBT-I (first-line treatment), never a substitute.
Sleep hygiene is a set of behavioral practices that promote quality sleep: regular bedtimes and wake times (including weekends); avoiding screens (phone, TV) 1 hour before bed; a dark, quiet, cool bedroom (18-20 degrees C); not using the bed for work or watching TV; limiting caffeine after 2 p.m. and alcohol at night; avoiding intense exercise within 3 hours of bed; and getting natural light exposure in the morning. On its own, sleep hygiene has limited efficacy for chronic insomnia, but it is an essential component of CBT-I.
Yes, the relationship is bidirectional and clinically relevant. Chronic insomnia increases the risk of arterial hypertension, type 2 diabetes, obesity, cardiovascular disease, and immune impairment. Conversely, chronic pain, sleep apnea, gastroesophageal reflux, nocturia, and RLS are common causes of secondary insomnia. Insomnia also raises the risk of depression and anxiety — and these disorders, in turn, perpetuate insomnia. Adequate insomnia treatment reduces these associated risks.
Sleep restriction is one of the most effective CBT-I techniques, although counterintuitive. It consists of limiting time in bed to estimated actual sleep time (e.g., if sleeping 5 h, stay only 5 h in bed). This creates homeostatic sleep pressure (more sleep "debt"), which increases sleep efficiency. Gradually, time in bed is expanded as efficiency improves. It is temporarily uncomfortable (increased sleepiness in the first weeks), but mid-term results are excellent.
Clinical protocols generally involve 8 to 12 sessions over 4-6 weeks for chronic insomnia. Patients often notice improvement in sleep quality after 4-6 sessions. The acupuncture physician will assess response and may recommend monthly maintenance cycles for recurrent cases. Acupuncture can be combined with CBT-I for enhanced results — acupuncture reduces physiologic hyperexcitability while CBT-I addresses cognitive and behavioral factors.
Seek medical evaluation if: difficulty sleeping persists for more than 3-4 weeks; insomnia significantly impairs daytime performance (work, school, relationships); you suspect sleep apnea (snoring, breathing pauses, intense daytime sleepiness); insomnia is associated with depressed mood or intense anxiety; or you are using alcohol or sleep medications regularly. The physician will identify the cause and recommend the most appropriate treatment — frequently CBT-I, with or without temporary pharmacologic support.
Related Reading
Deepen your knowledge with related articles